Accueil>>Signaling Pathways>> Immunology/Inflammation>> Interleukin Related>>Fezakinumab

Fezakinumab (Synonyms: ILV 094)

Catalog No.GC69104

Fezakinumab est un anticorps monoclonal contre l'interleukine 22 (IL-22). Fezakinumab peut être utilisé dans la recherche sur des maladies inflammatoires telles que le psoriasis et la polyarthrite rhumatoïde.

Products are for research use only. Not for human use. We do not sell to patients.

Fezakinumab Chemical Structure

Cas No.: 1007106-86-6

Taille Prix Stock Qté
1mg
315,00 $US
En stock
5mg
819,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Avis

Review for Fezakinumab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Fezakinumab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.